Fidelity Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Amarantus BioScience Holdings, Inc. (AMBS)

Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, r00kie, TheWizardOfPot, joboggi, Sir Francelote, Rosym
Search This Board:
Last Post: 9/3/2014 2:27:18 AM - Followers: 717 - Board type: Free - Posts Today: 6

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The company has licensed Eltoprazine, a Phase 2B ready Parkinsons Levadopa induced Dyskinesia. The company has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's Disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property rights for the diagnosis of Parkinson's Disease ("NuroPro") and the discovery of neurotrophic facotrs ("PhenoGuard"). For further information, please visit www.Amarantus.comor connect with the company on FacebookTwitter, LinkedIn & Google+



Initiating Studies for CLIA Launch at Icon Central Laboratories
September 2nd, 2014   8:00 am
Amarantus BioScience Holdings, Inc. - "Initiating Studies for CLIA Launch at Icon Central Laboratories"
Sept 2, 2014   8:26 a.m.
Amarantus Initiates CLIA Development of Alzheimer's Blood Diagnostic LymPro Test(R) at ICON Central Laboratories
Sept 2, 2014   6:00 a.m. 
Amarantus Appoints Iain Ross to Board of Directors
Aug. 29, 2014   7:57 a.m. 
Amarantus Reports Second Quarter 2014 Financial Results, Announces Business Update Call
Aug. 27, 2014   9:00 a.m  
Amarantus to Present at Upcoming Investor Conferences
Aug. 19, 2014   8:42 A.M. 
Amarantus Exercises Option to License Intellectual Property From University of Miami Bascom Palmer Eye Institute for Use of MANF in Retinal Disorders
Aug. 15, 2014   8:11 A.M. 
Amarantus BioScience Holdings, Inc. "Preparing Amarantus for the Up-list in 2H-14: Capital Markets Strategy"
Aug. 11, 2014   8:03 a.m. 
Amarantus Enters Into Research Collaboration With the Buck Institute for Research on Aging for MANF
Aug. 11, 2014   8:01 A.M. ET
OTC Trading Stock News: Amarantus Biosciences Holdings, Inc. Virtus Oil and Gas Corp, Cannabis Sativa, Inc. Creative Edge Nutrition, Inc. DNA Brands, Inc.
Aug. 5, 2014   8:00 A.M.
Amarantus BioScience Holdings, Inc. - "#C4CT Wrap-up and the Decision to Present Interim LP-002 Data"
Aug. 4, 2014   4:26 P.M.. 
#C4CT Summit Explored Emerging Theories on Traumatic Brain Injury, Chronic Traumatic Encephalopathy and Possible Links to Alzheimer's Disease
Aug. 4, 2014   8:00 A.M. 
Amarantus Announces Positive Top-Line Interim Clinical Data for Alzheimer's Blood Diagnostic LymPro Test(R)
Aug. 1, 2014   9:25 A.M. 
Amarantus Acquires Exclusive Option to License Alzheimer's Therapeutic IP of Dr. Thomas Arendt From University of Leipzig
Aug. 1, 2014   8:01 A.M.

SNNLive - Amarantus BioScience Holdings, Inc.
Published on June 21, 2014

SNNLive - Amarantus BioScience Holdings, Inc.
Published on May 21, 2014

Medical Dictionary (some often-used terms in AMBS PRs)

The substania nigra is an area of pigmented cells in the midbrain which is responsible for producing the neurotransmitter dopamine. This section of the brain plays an important role in the control of movement, and it also appears to interact in the process of addiction, as well. If you view a brain in cross-section, the substantia nigra is located in the midbrain, right at the tip of the brainstem.

The striatum is also called the striate body. It includes the caudate nucleus and the lentiform nucleus. The term striatum (striate) refers to the layered appearance of bands of gray matter that course from one of these nuclei to the other and represent the connections between them.

In living tissues, reinnervation describes the process by which post-synaptic neurons form new synapses or increase existing synaptic efficacy in order to compensate for a lack of pre-synaptic input from dead or otherwise dysfunctional pre-synaptic neurons.

Glial cell-derived neurotrophic factor, also known as GDNF is a protein that, in humans, is encoded by the GDNF gene.[1] GDNF is a small protein that potently promotes the survival of many types of neurons.[2

Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack

Pertinent Terms of Service

A. Is unlawful, threatening, abusive, harassing, defamatory, libelous, vulgar, hateful, deceptive, fraudulent, invasive of another's privacy, tortious, contains explicit or graphic descriptions or accounts of sexual acts (including but not limited to sexual language of a violent or threatening nature directed at another individual or group of individuals), or otherwise violates our rules or policies; This includes signatures as well. 
B. Attacks, verbally or otherwise, any other user, the website, any non-public figure, or any agents or employees of iHub; This includes signatures as well. 
C. Victimizes, harasses, degrades, or intimidates an individual or group of individuals on the basis of religion, gender, sexual orientation, race, ethnicity, age, or disability; This includes signatures as well. 

             A reminder, if your post is removed and you think it should be restored go to mailbox, and then click on removed posts, and follow the directions. Post that talk about other members, or other companies violate the TOS. Those posts are routinely deleted. It is easy to talk about AMBS without talking about the posters or in most cases, other companies and products.


smiley  Gerald Commissiong, President and CEO, is scheduled to present to investors at the 16th Annual Rodman & Renshaw Healthcare Conference to be held September 8-10, 2014 at the New York Palace Hotel in New York City. The presentation is scheduled for Tuesday, September 9th at 2:30 PM ET and will be web cast live, please visit the Company's IR Events section to participate. Additional information about the conference can be found at

Mr. Commissiong is also scheduled to present at the Aegis Capital Healthcare and Technology Conference to be held at the Wynn Las Vegas on September 10-13, 2014. His presentation will take place on Thursday, September 11th at 2:30 PM PT. Conference information may be found at

Amarantus will also be participating in the First Annual Zacks Healthcare Meetup on Monday, September 8th.

Attendees who wish to meet with management one on one may contact the conference organizers or our Investor Relations department at

smiley  AMBS expect to complete the agreement with Big Pharma, partner by the end of the summer.




Company Information

Amarantus BioScience Holdings, Inc.
c/o Janssen Labs @ QB3
953 Indiana Street
San Francisco, CA 94107

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva

Phone: (408) 737-2734
Fax: (408) 852-4427

Investor Relations

Aimee Boutcher
Director of Investor Relations
Amarantus BioScience Holdings, Inc

408-737-2734 x101

Transfer Agent

VStock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, NY 11516
Attn: Allison Niccols

Phone: 212-828-8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
AMBS News: Current Report Filing (8-k) 09/02/2014 05:26:11 PM
AMBS News: Current Report Filing (8-k) 08/29/2014 08:36:44 AM
AMBS News: Current Report Filing (8-k) 08/27/2014 04:00:45 PM
AMBS News: Proxy Statement (definitive) (def 14a) 08/19/2014 04:55:16 PM
News News Alert: Current Report Filing (8-k) 09/02/2014 05:26:11 PM
#108245  Sticky Note Here are my shorthand notes... tsuguy 09/02/14 05:59:05 PM
#107220  Sticky Note About Amarantus BioScience, Inc. Rosym 08/07/14 04:32:28 PM
#104968  Sticky Note MJFF is firm with their notion that NFs joboggi 07/17/14 02:01:07 AM
#104282  Sticky Note Complete Listing of Gerald's Response to Questions (Twitter 7/10/14) r00kie 07/10/14 07:59:21 PM
#104067  Sticky Note That's not what it says. It modifies barcode27 07/08/14 03:23:31 PM
#108264   I will like AMBS at nine cents, or joboggi 09/03/14 02:27:18 AM
#108263   Joboggi, there are lots of other stocks traded sante1 09/03/14 02:18:23 AM
#108262   per the notes taken and posted in a joboggi 09/03/14 12:42:05 AM
#108261   do the math, that means that they are joboggi 09/03/14 12:32:40 AM
#108260   There is a stickie with the notes from joboggi 09/03/14 12:28:25 AM
#108259   Very nice call on the range. Deputy123 09/03/14 12:18:27 AM
#108258   What? Vis567 09/02/14 11:06:45 PM
#108256   $$$$$) myersvodka 09/02/14 11:02:27 PM
#108255   What was the call? Any good news??? Vis567 09/02/14 10:57:16 PM
#108254   This is nothing but more obfuscation and outright joboggi 09/02/14 10:22:46 PM
#108253   So, ah, no revenue this year, no money joboggi 09/02/14 10:14:15 PM
#108252   $AMBS announces huge LymPro revenue guidance: $150 million/year Slmiley 09/02/14 09:31:26 PM
#108251   because i need you to pump the stock AztecJames 09/02/14 08:02:09 PM
#108250   What's the reason your still in? Just leave sante1 09/02/14 08:00:28 PM
#108249   Missed all quarterly goals, and they now predict AztecJames 09/02/14 07:43:51 PM
#108248   Nice rundown, Stickied. TheWizardOfPot 09/02/14 06:40:02 PM
#108247   They had the CC today? How much did joboggi 09/02/14 06:09:39 PM
#108246   I heard that AMBS got a gazillion dollars joboggi 09/02/14 06:08:21 PM
#108245   Here are my shorthand notes... tsuguy 09/02/14 05:59:05 PM
#108244   Still going on... Mgoblue10 09/02/14 05:52:21 PM
#108243   How did the call go? AztecJames 09/02/14 05:24:00 PM
#108242   yes! porsche2006 09/02/14 04:37:06 PM
#108241   Not too sure what the pps will be SmurfVA 09/02/14 04:34:11 PM
#108240   i'll take that as well. LOL porsche2006 09/02/14 04:30:13 PM
#108239   Unless we have really big news, todays high Citrati 09/02/14 04:23:26 PM
#108238   I expect call to be good. professional shake porsche2006 09/02/14 04:14:48 PM
#108237   shorts won today.... JPetroInc 09/02/14 04:11:50 PM
#108236   Im in, look forward to the CC today . fulleroots 09/02/14 03:35:30 PM
#108235   One more target to go.. guardiangel 09/02/14 03:30:29 PM
#108234   Don't want to jinx ya, we still have Citrati 09/02/14 12:33:34 PM
#108233   What does a lab like ICON charge for dshade 09/02/14 10:06:21 AM
#108232   Point made, but that gap:) TrendVestor 09/02/14 09:44:03 AM
#108231   Let me publicly say congratulations to GC and Mgoblue10 09/02/14 09:41:37 AM
#108230   Chairmans Blog : Initiating Studies for CLIA Launch abbey1212 09/02/14 08:51:40 AM
#108229   [AMBS] WHALES ARE HERE !! MULTI-LEVEL DOLLARS EXPECTED >>>>>>>>>> trader22 09/02/14 08:40:43 AM
#108228   Today's estimates ikearch 09/02/14 08:35:14 AM
#108227   Any guess what would be the today's target? Vis567 09/02/14 08:04:41 AM
#108226   [AMBS] HUGE NEWS !! trader22 09/02/14 07:48:01 AM
#108225   Ask 0,41 !? Greenspam2 09/02/14 07:17:09 AM
#108224   Good morning America: ICON= symbol of excellence !!!! Greenspam2 09/02/14 06:38:18 AM
#108223   CLIA partner today news: mstrike 09/02/14 06:10:47 AM
#108222   Sooner than many may think.... Goldstrike 09/02/14 03:02:17 AM
#108221   Exactly. TheWizardOfPot 09/02/14 02:56:29 AM
#108220   yup, those crazy profitable fools! sumotrader 09/02/14 02:54:56 AM
#108219   Thank you Barcode27 for the information in my Natural Treasures 09/02/14 01:58:46 AM
#108218 Natural Treasures 09/02/14 01:45:55 AM
#108217   MANF could be a real opportunity. It seems joboggi 09/02/14 12:20:11 AM
#108216   Regardless this stock will rise on its own shamalam 09/01/14 07:50:02 PM
#108215   Either way their b/s needs to stop. I've TheWizardOfPot 09/01/14 04:55:59 PM
#108214   Only newbies go to PnDs to get actual TheWizardOfPot 09/01/14 04:55:05 PM